IVP Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 16, 2026, 2:40 am

All Competitor Stocks of IVP Ltd

Last Updated: January 1, 2026, 5:46 am

Below is a detailed analysis of the quarterly data for IVP Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 146.95 Cr.. The value appears strong and on an upward trend. It has increased from 138.19 Cr. (Jun 2025) to 146.95 Cr., marking an increase of 8.76 Cr..
• For Expenses, as of Sep 2025, the value is 138.85 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 133.94 Cr. (Jun 2025) to 138.85 Cr., marking an increase of 4.91 Cr..
• For Operating Profit, as of Sep 2025, the value is 8.10 Cr.. The value appears strong and on an upward trend. It has increased from 4.25 Cr. (Jun 2025) to 8.10 Cr., marking an increase of 3.85 Cr..
• For OPM %, as of Sep 2025, the value is 5.51%. The value appears strong and on an upward trend. It has increased from 3.08% (Jun 2025) to 5.51%, marking an increase of 2.43%.
• For Other Income, as of Sep 2025, the value is 0.89 Cr.. The value appears to be declining and may need further review. It has decreased from 1.06 Cr. (Jun 2025) to 0.89 Cr., marking a decrease of 0.17 Cr..
• For Interest, as of Sep 2025, the value is 2.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.11 Cr. (Jun 2025) to 2.19 Cr., marking an increase of 0.08 Cr..
• For Depreciation, as of Sep 2025, the value is 1.50 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.50 Cr..
• For Profit before tax, as of Sep 2025, the value is 5.30 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Jun 2025) to 5.30 Cr., marking an increase of 3.60 Cr..
• For Tax %, as of Sep 2025, the value is 24.53%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Jun 2025) to 24.53%, marking a decrease of 5.47%.
• For Net Profit, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.19 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 2.81 Cr..
• For EPS in Rs, as of Sep 2025, the value is 3.87. The value appears strong and on an upward trend. It has increased from 1.15 (Jun 2025) to 3.87, marking an increase of 2.72.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 5:10 am

Last Updated: September 5, 2025, 7:55 am

Last Updated: December 4, 2025, 1:27 am

Below is a detailed analysis of the balance sheet data for IVP Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
• For Reserves, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 134.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 104.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 4.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 106.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 19.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 331.00 Cr.. The value appears to be improving (decreasing). It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 261.00 Cr., marking a decrease of 17.00 Cr..
• For Total Assets, as of Sep 2025, the value is 331.00 Cr.. The value appears to be declining and may need further review. It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..

Notably, the Reserves (134.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for IVP Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
• For Cash EPS (Rs.), as of Mar 25, the value is 16.50. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 16.50, marking a decrease of 0.75.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 521.77. It has decreased from 528.65 (Mar 24) to 521.77, marking a decrease of 6.88.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 27.86. This value is within the healthy range. It has decreased from 29.88 (Mar 24) to 27.86, marking a decrease of 2.02.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 24.52 (Mar 24) to 22.31, marking a decrease of 2.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 14.77. This value is within the healthy range. It has decreased from 16.10 (Mar 24) to 14.77, marking a decrease of 1.33.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.95, marking a decrease of 0.94.
• For PBDIT Margin (%), as of Mar 25, the value is 5.33. This value is below the healthy minimum of 10. It has decreased from 5.65 (Mar 24) to 5.33, marking a decrease of 0.32.
• For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 4.63 (Mar 24) to 4.27, marking a decrease of 0.36.
• For PBT Margin (%), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 10. It has decreased from 3.04 (Mar 24) to 2.83, marking a decrease of 0.21.
• For Net Profit Margin (%), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to 2.09, marking a decrease of 0.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 9.47 (Mar 24) to 8.11, marking a decrease of 1.36.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.32. This value is within the healthy range. It has decreased from 19.06 (Mar 24) to 16.32, marking a decrease of 2.74.
• For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has decreased from 3.71 (Mar 24) to 3.25, marking a decrease of 0.46.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 0.74, marking an increase of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.59. It has increased from 1.53 (Mar 24) to 1.59, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 24) to 1.32, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has increased from 0.90 (Mar 24) to 0.91, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.77. This value is within the healthy range. It has increased from 5.22 (Mar 24) to 6.77, marking an increase of 1.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 20. It has decreased from 12.62 (Mar 24) to 9.10, marking a decrease of 3.52.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.04. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 6.04, marking a decrease of 2.65.
• For Earning Retention Ratio (%), as of Mar 25, the value is 90.90. This value exceeds the healthy maximum of 70. It has increased from 87.38 (Mar 24) to 90.90, marking an increase of 3.52.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has increased from 91.31 (Mar 24) to 93.96, marking an increase of 2.65.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.69. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 3.69, marking an increase of 0.14.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 3. It has increased from 2.41 (Mar 24) to 2.45, marking an increase of 0.04.
• For Enterprise Value (Cr.), as of Mar 25, the value is 252.41. It has increased from 244.62 (Mar 24) to 252.41, marking an increase of 7.79.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.46, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 8.77, marking an increase of 0.85.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
• For Retention Ratios (%), as of Mar 25, the value is 90.89. This value exceeds the healthy maximum of 70. It has increased from 87.37 (Mar 24) to 90.89, marking an increase of 3.52.
• For Price / BV (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.21 (Mar 24) to 1.07, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis